Association between polymyositis and hepatitis C virus infection: Treatment-related difficulties;Association entre polymyosite et infection par le virus de l'hepatite C. Les difficultes du traitement

Revue de Medecine Interne

Volumn 21, Issue 6, 2000, Pages 542-546

  Alric, L ^a   Partensky, J ^a   Reynaud, D ^a   Rauzy, O ^b   Duffaut, M ^a  

^a CHU PURPAN   (France)

^b Toulouse University   (France)

Author keywords

HCV; Interferon; Intravenous gamma globulins; Polymyositis; Viral hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DYSPNEA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER INJURY; MALE; MUSCLE WEAKNESS; POLYMYOSITIS;

EID: 0034212712     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)89230-9     Document Type: Article

References (16)

1. Lunel F. Hépatite C et anomalies immunologiques. GastroentéRol Clin Biol 1994 ; 18 : 829-38.
2. Cacoub P, Renou C, Cohen P, Loustau-Ratti V, Loury I, Yamamoto AM. Manifestations extrahépatiques de l'infection par le VHC : Étude prospective multicentrique nationale chez 235 patients. Rev Méd Interne 1997 ; 18 : 76s.
3. Nishikai M, Miyairi M, Kosaka S. Dermatomyositis following infection with hepatitis C virus. J Rheumatol 1994 ; 21 : 1584-5.
4. Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW. Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 1995 ; 38 : 437-9.
5. Ueno Y, Kondo K, Kidokoro N, Kobashi R, Kanaji K, Matsumura T. Hepatitis C infection and polymyositis. Lancet 1995 ; 346 : 319-20.
6. Arai H, Tanaka M, Ohta K, Kojo T, Nijima K, Imawari M. Symptomatic myopathy associated with interferon therapy for chronic hepatitis C. Lancet 1995 ; 345 : 582.
7. Horsmans Y, Geubel AP. Symptomatic myopathy in hepatitis C infection without interferon therapy. Lancet 1995 ; 345 : 1236.
8. Matsuya M, Abe T, Tosaka M, Yonezawa K, Ono A, Ikeda N, et al. The first case of polymyositis associated with interferon therapy. Intern Med 1994 ; 33 : 806-8.
9. Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Méd 1997 ; 157 : 2497-500.
10. Rivera J, De Diego A, Trinchet M, Garcia Monforte A. Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol 1997 ; 36 : 981-5.
11. Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995 ; 22 : 668-74.
12. Bon E, Cantagrel A, Moulinier L, Laroche M, Duffaut M, Arlet P, et al. Rheumatic manifestations of chronic hepatitis C and response to the treatment with interferon alpha-2b. Rev Rhum (Ed Fr) 1994 ; 61 : 497-504.
13. Kalovidouris AE. The role of cytokines in polymyositis: Interferon-gamma induces class II and enhances class I major histocompatibility complex antigen expression on cultured human muscle cells. J Lab Clin Med 1992 ; 120 : 244-51.
14. Ferri C, La Civita L, Fazzi P, Pasero G, Zignego AL. Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection. Arthritis Rheum 1996 ; 39 : 1074-5.
15. Ferri C, La Civita L, Fazzi P, Solfanelli S, Lombardini F, et al. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. Br J Rheumatol 1997 ; 36 : 360-5.
16. Cherin P, Piette JC, Wechsler B, Blétry O, Ziza JM, Laraki R, et al. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: An open study in 11 adult patients. J Rheumatol 1994 ; 21 : 1092-7.